Bristol-Myers Subpoenaed By DOJ For Abilify Info
Bristol-Myers Squibb Co. received a U.S. Department of Justice subpoena in January requesting information relating to, among other things, the sales and marketing of its antipsychotic drug Abilify, the company said...To view the full article, register now.
Already a subscriber? Click here to view full article